Nls Pharmaceutics Ltd

CUSIP H57830137COM NEWQ3 2025

Nls Pharmaceutics Ltd — Owners — 13D/13G Beneficial Ownership · FBInvestor

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

11.0%

Max % of class reported

Institutional Holders

13F filers (latest quarter)

3 filings · latest Feb 14, 2025

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	Feb 14, 2025	Lind Global Fund II LP	13G/A	11.0%	59.8K	SEC
2	Nov 14, 2024	Armistice Capital, LLC	13G	10.0%	129.5K	SEC
3	Nov 14, 2024	Lind Global Fund II LP	13G/A	8.1%	103.5K	SEC

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Bvf Inc/Il	143.7K	$262.9K
2	Ubs Group AG	38	$70